Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
EARLY last year, drugmaker Mallinckrodt plc spent US$1.3 billion to buy a company that sold an injectable form of acetaminophen - essentially Tylenol in a liquid solution.
Within months, the new owner more than doubled the price of the drug, called Ofirmev. Revenue from...